CytoSelect Cell Viability and Cytotoxicity Assay |
CBA-240 |
Cell Biolabs |
96 assays |
EUR 470.4 |
Description: The CytoSelect Cell Viability and Cytotoxicity Assay Kit provides a simple format for monitoring cell viability via metabolic activity. Live cells are detected with either MTT (colorimetric detection) or Calcein AM (fluorometric detection). Dead cells are detected by EthD-1 reagent (fluorometric). All 3 detection reagents are included, along with Saponin (a cell death initiator). Prior to the assay, cells may be treated with compounds or agents that affect cell viability. This kit is suitable for eukaryotic cells, not yeast or bacteria. |
Biomarker Assay Laboratories manufactures the fda approval of biomarker assay reagents distributed by Genprice. The Fda Approval Of Biomarker Assay reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact biomarker assay. Other Fda products are available in stock. Specificity: Fda Category: Approval Group: Of Biomarker
MTT Cell Proliferation and Cytotoxicity Assay Kit |
BosterBio |
1 kit (for 500 assays) |
EUR 115.2 |
CF488A and 7-AAD Apoptosis Assay Kit |
Biotium |
1KIT |
EUR 339.6 |
Description: Minimum order quantity: 1 unit of 1KIT |
Of Biomarker information
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF640R conjugate, 0.1mg/mL |
BNC401943-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF488A conjugate, 0.1mg/mL |
BNC881943-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF488A conjugate, 0.1mg/mL |
BNC881943-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF594 conjugate, 0.1mg/mL |
BNC941943-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF594 conjugate, 0.1mg/mL |
BNC941943-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF405S conjugate, 0.1mg/mL |
BNC041943-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF405S conjugate, 0.1mg/mL |
BNC041943-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), Biotin conjugate, 0.1mg/mL |
BNCB2430-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), Biotin conjugate, 0.1mg/mL |
BNCB2430-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), Biotin conjugate, 0.1mg/mL |
BNCB2570-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), Biotin conjugate, 0.1mg/mL |
BNCB2570-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF647 conjugate, 0.1mg/mL |
BNC472430-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF647 conjugate, 0.1mg/mL |
BNC472430-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF568 conjugate, 0.1mg/mL |
BNC682430-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF568 conjugate, 0.1mg/mL |
BNC682430-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF594 conjugate, 0.1mg/mL |
BNC942430-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF594 conjugate, 0.1mg/mL |
BNC942430-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |